Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms

12/2020: First paper describing the global downstream effectors of mutated JAK2 kinase and validating their functional relevance for maintenance of MPN published in Nature. Great collaborative project with the group of Matthias Mann at the MPI Munich.